Business Combinations

9 Months Ended

Dec. 31, 2011

Business Combinations [Abstract]

Business Combinations

2. Business Combinations

     On December 30, 2010, we acquired all of the outstanding shares of US Oncology Holdings, Inc. ("US Oncology") for approximately $2.1 billion, consisting of cash consideration of $0.2 billion, net of cash acquired, and the assumption of liabilities with a fair value of $1.9 billion. The cash paid at acquisition was funded from cash on hand. As an integrated oncology company, US Oncology is affiliated with community-based oncologists, and works with patients, hospitals, payers and the medical industry across all phases of the cancer research and delivery continuum. The acquisition of US Oncology expands our existing specialty pharmaceutical distribution business and adds practice management services for oncologists. Financial results for US Oncology have been included in the results of operations within our Distribution Solutions segment beginning in the fourth quarter of 2011.

     During the third quarter of 2012, the fair value measurements of assets acquired and liabilities assumed as of the acquisition date were completed. The following table summarizes the final amounts of the fair values recognized for the assets acquired and liabilities assumed as of the acquisition date, as well as measurement period adjustments made in the first nine months of 2012 to the amounts initially recorded in 2011. The measurement period adjustments during the first nine months of 2012 did not have a significant impact on our condensed consolidated statements of operations, balance sheets or cash flows in any period, and, therefore, we have not retrospectively adjusted our financial statements.

		Amounts
		Previously						Amounts
		Recognized as of			Measurement			Recognized as of
		Acquisition Date			Period			Acquisition Date
(In millions)		(Provisional) (1)			Adjustments			(Final)
Current assets, net of cash acquired	$	662		$	(13	)	$	649
Goodwill		808			20			828
Intangible assets		1,007			(14	)		993
Other long-term assets		354			(6	)		348
Current liabilities		(489	)		(1	)		(490	)
Current portion of long-term debt		(1,735	)		—			(1,735	)
Other long-term liabilities		(338	)		16			(322	)
Other stockholders' equity		(25	)		(2	)		(27	)
Net assets acquired, less cash and cash equivalents	$	244		$	—		$	244

(1) As previously reported in our Form 10-K for the year ended March 31, 2011.

     During the last two years, we also completed a number of other smaller acquisitions within both of our operating segments. Financial results for our business acquisitions have been included in our condensed consolidated financial statements since their respective acquisition dates. Purchase prices for our business acquisitions have been allocated based on estimated fair values at the date of acquisition.

     Goodwill recognized for our business acquisitions is generally not expected to be deductible for tax purposes. The pro forma results of operations for our business acquisitions and the results of operations for these acquisitions since the acquisition date have not been presented because the effects were not material to the condensed consolidated financial statements on either an individual or an aggregate basis.